MUC1 and malignant colon neoplasm: Furthermore, under the delivery of mucin-1-dimer aptamer-modified CNN, epirubicin and a mixture containing epirubicin and melittin exhibited more effective antitumor effects than free epirubicin treatment in a colon cancer mouse model bearing C26 cells.